Stress and Angiotensin II: Novel Therapeutic Opportunities

被引:31
作者
Armando, Ines [1 ]
Seltzer, Alicia [1 ]
Bregonzio, Claudia [1 ]
Saavedra, Juan M. [1 ]
机构
[1] NIMH, Sect Pharmacol, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
关键词
D O I
10.2174/1568007033482661
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Angiotensin II was initially described as a hormone of peripheral origin, the active end product of the Renin-Angiotensin System. The subsequent discovery that Angiotensin II was locally formed and selectively regulated in most organs indicated that tissue Angiotensin II systems might play additional important roles. After initial controversy, the presence of an Angiotensin II system in the brain is now universally accepted. Brain Angiotensin II is probably involved in the regulation of many brain functions. Angiotensin II AT(1) receptors are localized not only in areas related to the regulation of autonomic and endocrine control, but also in many other areas of the brain involved in emotional, sensory and motor functions. Angiotensin II AT(2) receptors are more abundant in brain areas related to sensory and motor control. The roles of brain Angiotensin II appear to be multiple and complex. In addition to a regulatory role in the control of the autonomic and hormone systems, the peptide participates in brain development, sensory processes, cognition and in the regulation of cerebrovascular flow. Recent developments indicate that blockade of the brain Angiotensin II AT(1) receptors not only contributes to a significant blood pressure decrease in hypertension, but that simultaneous antagonism of peripheral and brain AT(1) receptors reduces the sympathoadrenal and hormonal responses to stress and prevents stress-induced gastric injury. A novel role emerges for the use of peripheral and centrally acting AT(1) receptor antagonists as therapeutically advantageous for the treatment of stress-related disorders.
引用
收藏
页码:413 / 419
页数:7
相关论文
共 103 条
[1]
INCREASED EXPRESSION OF TYPE-1 ANGIOTENSIN-II RECEPTORS IN THE HYPOTHALAMIC PARAVENTRICULAR NUCLEUS FOLLOWING STRESS AND GLUCOCORTICOID ADMINISTRATION [J].
AGUILERA, G ;
KISS, A ;
LUO, X .
JOURNAL OF NEUROENDOCRINOLOGY, 1995, 7 (10) :775-783
[2]
DIRECT REGULATION OF HYPOTHALAMIC CORTICOTROPIN-RELEASING-HORMONE NEURONS BY ANGIOTENSIN-II [J].
AGUILERA, G ;
YOUNG, WS ;
KISS, A ;
BATHIA, A .
NEUROENDOCRINOLOGY, 1995, 61 (04) :437-444
[3]
Effect of electrolytic and neurotoxic lesions of the median raphe nucleus on anxiety and stress [J].
Andrade, TGCS ;
Graeff, FG .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 70 (01) :1-14
[4]
[Anonymous], HDB CHEM NEUROANATOM
[5]
Peripheral administration of an angiotensin II AT1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress [J].
Armando, I ;
Carranza, A ;
Nishimura, Y ;
Hoe, KL ;
Barontini, M ;
Terrón, JA ;
Falcón-Neri, A ;
Ito, T ;
Juorio, AV ;
Saavedra, JM .
ENDOCRINOLOGY, 2001, 142 (09) :3880-3889
[6]
Increased angiotensin II AT1 receptor expression in paraventricular nucleus and hypothalamic-pituitary-adrenal axis stimulation in AT2 receptor gene disrupted mice [J].
Armando, I ;
Terrón, JA ;
Falcón-Neri, A ;
Takeshi, I ;
Häuser, W ;
Inagami, T ;
Saavedra, JM .
NEUROENDOCRINOLOGY, 2002, 76 (03) :137-147
[7]
BAINS JS, 1995, AM J PHYSIOL, V268, pR62
[8]
IDENTIFICATION AND CHARACTERIZATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES IN HUMAN BRAIN [J].
BARNES, JM ;
STEWARD, LJ ;
BARBER, PC ;
BARNES, NM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 230 (03) :251-258
[9]
Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase [J].
Bedecs, K ;
Elbaz, N ;
Sutren, M ;
Masson, M ;
Susini, C ;
Strosberg, AD ;
Nahmias, C .
BIOCHEMICAL JOURNAL, 1997, 325 :449-454
[10]
BELDENT V, 1993, J BIOL CHEM, V268, P26428